Literature DB >> 34406905

Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.

Steven L Gonias1.   

Abstract

Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) are serine proteases and major activators of fibrinolysis in mammalian systems. Because fibrinolysis is an essential component of the response to tissue injury, diverse cells, including cells that participate in the response to injury, have evolved receptor systems to detect tPA and uPA and initiate appropriate cell-signaling responses. Formation of functional receptor systems for the plasminogen activators requires assembly of diverse plasma membrane proteins, including but not limited to: the urokinase receptor (uPAR); integrins; N-formyl peptide receptor-2 (FPR2), receptor tyrosine kinases (RTKs), the N-methyl-d-aspartate receptor (NMDA-R), and low-density lipoprotein receptor-related protein-1 (LRP1). The cell-signaling responses elicited by tPA and uPA impact diverse aspects of cell physiology. This review describes rapidly evolving knowledge regarding the structure and function of plasminogen activator receptor assemblies. How these receptor assemblies regulate innate immunity and inflammation is then considered.

Entities:  

Keywords:  inflammation; innate immunity; tissue-type plasminogen activator; uPAR; urokinase-type plasminogen activator

Mesh:

Substances:

Year:  2021        PMID: 34406905      PMCID: PMC8560384          DOI: 10.1152/ajpcell.00269.2021

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  188 in total

Review 1.  Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology.

Authors:  P Mignatti; D B Rifkin
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

Review 2.  uPAR: a versatile signalling orchestrator.

Authors:  Francesco Blasi; Peter Carmeliet
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

3.  Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system.

Authors:  Erin H Norris; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-02       Impact factor: 11.205

Review 4.  The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.

Authors:  Daniela Alfano; Paola Franco; Immacolata Vocca; Nadia Gambi; Viviana Pisa; Alessandro Mancini; Mario Caputi; Maria Vincenza Carriero; Ingram Iaccarino; Maria Patrizia Stoppelli
Journal:  Thromb Haemost       Date:  2005-02       Impact factor: 5.249

Review 5.  The roles of protein C and thrombomodulin in the regulation of blood coagulation.

Authors:  C T Esmon
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

6.  Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones.

Authors:  Michael S Perkinton; James K Ip; Gemma L Wood; Andrew J Crossthwaite; Robert J Williams
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

7.  Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin.

Authors:  J Parkkinen; H Rauvala
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury.

Authors:  Yasuhiro Shiga; Akina Shiga; Pinar Mesci; HyoJun Kwon; Coralie Brifault; John H Kim; Jacob J Jeziorski; Chanond Nasamran; Seiji Ohtori; Alysson R Muotri; Steven L Gonias; Wendy M Campana
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

View more
  3 in total

1.  The LRP1/CD91 ligands, tissue-type plasminogen activator, α2-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling.

Authors:  Elisabetta Mantuano; Pardis Azmoon; Michael A Banki; Cory B Gunner; Steven L Gonias
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

2.  Decreased low-density lipoprotein receptor-related protein 1 expression in pro-inflammatory monocytes is associated with subclinical atherosclerosis.

Authors:  Ricardo A Albertini; Juan C Nicolas; Virginia Actis Dato; Darío G Ferrer; María E Tinti; Raúl H Capra; Gustavo A Chiabrando
Journal:  Front Cardiovasc Med       Date:  2022-07-26

3.  Integrated transcriptomics and metabolomics analysis of the hippocampus reveals altered neuroinflammation, downregulated metabolism and synapse in sepsis-associated encephalopathy.

Authors:  Kejia Xu; Hui Li; Bing Zhang; Meini Le; Qiong Huang; Rao Fu; Giorgia Croppi; Gang Qian; Junjie Zhang; Guangming Zhang; Yinzhong Lu
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.